Calliditas Therapeutics AB OverviewCalliditas Therapeutics AB Net Income
Profitability analysis for CALT.
Quarterly Net Income
-$47.48M
↑ 48.36% YoY
As of Jun 2024
Annual Net Income (TTM)
-$480.36M
↓ 64.37% YoY
Trailing 12 months ending Jun 2024
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...